STEPHEN WHITE
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SAVANNAH, GA NPI 1265486229
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology GA NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$9,542.01
- Category: General Payments
- Program years: PY2018–2024
- Record count: 570
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $931.79 across 46 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $931.79 | 46 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $152.64 | 8 |
| Regeneron Healthcare Solutions, Inc. | $114.98 | 5 |
| PFIZER INC. | $82.90 | 4 |
| Merck Sharp & Dohme Corporation | $68.46 | 3 |
| Acerta Pharma LLC | $61.06 | 3 |
| Rigel Pharmaceuticals, Inc. | $54.31 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $51.42 | 3 |
| Daiichi Sankyo Inc. | $40.13 | 2 |
| Astellas Pharma US Inc | $38.31 | 2 |
| ABBVIE INC. | $31.12 | 2 |
| Brainlab, Inc. | $28.87 | 1 |
| Janssen Biotech, Inc. | $28.50 | 1 |
| Ipsen Biopharmaceuticals, Inc | $23.12 | 1 |
| Alnylam Pharmaceuticals Inc. | $21.46 | 1 |
| BeiGene USA, Inc. | $19.09 | 1 |
| Genentech USA, Inc. | $18.94 | 1 |
| JAZZ PHARMACEUTICALS INC. | $18.03 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $17.61 | 1 |
| EISAI INC. | $16.55 | 1 |
| ARRAY BIOPHARMA INC | $16.52 | 1 |
| SpringWorks Therapeutics, Inc. | $14.07 | 1 |
| ADC Therapeutics America, Inc. | $13.70 | 1 |
By program year
Records — PY2024 (46)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.